Dahms Bradford D. bought JBIO
July 14, 2025 · Form 4 insider transaction
Dahms Bradford D. bought 526,000 shares of Jade Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
526,000
Price
$0.00
Total value
N/A
InsiderDahms Bradford D.
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 14, 2025
Filing dateJuly 14, 2025
Shares owned after526,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase 526,000 shares of the Issuer's common stock, one quarter of which will vest on July 14, 2026, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.